Whitehawk Therapeutics Inc (WHWK) Stock Price, Quote & News

Company Profile

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Industry: Biotechnology

Sector: Healthcare

Phone: 551 321 2234

Website: ir.whitehawktx.com

Address:

2 Headquarters Plaza, East Building 11th Floor, Morristown, United States

BillyWithrow1092 Nov. 7 at 4:30 PM

$WHWK sees accumulation from small-cap investors. AITX strengthens global market momentum with AI deployments that drive measurable safety and productivity improvements.

0 · Reply

IsabellaDC Oct. 31 at 3:03 PM

$WHWK Former runner fired a swing alert. No position.

0 · Reply

StackinGreen Oct. 26 at 11:44 PM

$WHWK

0 · Reply

Ka1ch123 Oct. 24 at 8:28 PM

$WHWK here on news

0 · Reply

1_ofThe_orig_Moonboyz Oct. 22 at 11:05 AM

$WHWK Thanks to BYND got lots of time to tuck this away and wait for 5$

0 · Reply

TendyWendy Oct. 21 at 10:28 PM

$WHWK no it didn’t

0 · Reply

swimger1982 Oct. 21 at 10:21 PM

$WHWK never happened

0 · Reply

TendyWendy Oct. 21 at 2:01 PM

$WHWK getting ready for a big move up after morning dip

0 · Reply

TendyWendy Oct. 21 at 1:41 PM

$WHWK come on …

0 · Reply

KDoc88 Oct. 21 at 12:12 PM

$WHWK they are trying hard to keep this down but they can’t 😂

0 · Reply

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

Nov 6, 2025, 8:00 AM EST - 8 days ago

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Oct 24, 2025, 12:30 PM EDT - 21 days ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

Oct 16, 2025, 8:30 AM EDT - 4 weeks ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

TEM

Sep 8, 2025, 6:44 PM EDT - 2 months ago

Whitehawk Therapeutics, Inc. (WHWK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 8:00 AM EDT - 2 months ago

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Aug 7, 2025, 8:00 AM EDT - 3 months ago

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Jul 22, 2025, 8:00 AM EDT - 4 months ago

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jun 19, 2025, 8:00 AM EDT - 5 months ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

May 28, 2025, 8:00 AM EDT - 6 months ago

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

May 21, 2025, 8:00 AM EDT - 6 months ago

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

May 8, 2025, 4:05 PM EDT - 6 months ago

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

Mar 26, 2025, 8:00 AM EDT - 8 months ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 19, 2025, 11:52 AM EDT - 8 months ago

Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 4:00 PM EDT - 8 months ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

BillyWithrow1092 Nov. 7 at 4:30 PM

$WHWK sees accumulation from small-cap investors. AITX strengthens global market momentum with AI deployments that drive measurable safety and productivity improvements.

0 · Reply

IsabellaDC Oct. 31 at 3:03 PM

$WHWK Former runner fired a swing alert. No position.

0 · Reply

StackinGreen Oct. 26 at 11:44 PM

$WHWK

0 · Reply

Ka1ch123 Oct. 24 at 8:28 PM

$WHWK here on news

0 · Reply

1_ofThe_orig_Moonboyz Oct. 22 at 11:05 AM

$WHWK Thanks to BYND got lots of time to tuck this away and wait for 5$

0 · Reply

TendyWendy Oct. 21 at 10:28 PM

$WHWK no it didn’t

0 · Reply

swimger1982 Oct. 21 at 10:21 PM

$WHWK never happened

0 · Reply

TendyWendy Oct. 21 at 2:01 PM

$WHWK getting ready for a big move up after morning dip

0 · Reply

TendyWendy Oct. 21 at 1:41 PM

$WHWK come on …

0 · Reply

KDoc88 Oct. 21 at 12:12 PM

$WHWK they are trying hard to keep this down but they can’t 😂

0 · Reply

Asrm088 Oct. 20 at 11:48 PM

$WHWK 3+ tomorrow?

2 · Reply

JamiH2O Oct. 20 at 8:04 PM

$WHWK

0 · Reply

KDoc88 Oct. 20 at 8:00 PM

$WHWK boom!!!

0 · Reply

1_ofThe_orig_Moonboyz Oct. 20 at 6:13 PM

$WHWK Everything else is popping. Might as well send this to 5$ too

1 · Reply

TendyWendy Oct. 20 at 6:06 PM

$WHWK just entered today . Great stock undervalued.

0 · Reply

_www_larval_com_ Oct. 20 at 5:08 PM

$WHWK just shot 4% higher to 15% (~932Kv) a few minutes ago, 11/21 options, follow for more volatility.

0 · Reply

KDoc88 Oct. 20 at 2:58 PM

$WHWK let’s go!!

0 · Reply

StackinGreen Oct. 20 at 2:41 PM

$WHWK

0 · Reply

swimger1982 Oct. 19 at 2:48 PM

$WHWK

1 · Reply

ChartChartist Oct. 19 at 1:51 AM

$BCG Most exciting ticker in Oct 20th week. Take all the profits and giving them to quality traders. Is that you? $EQ.X big daily candle $MIGI extra strong $WHWK more down $ADTX charmed

1 · Reply

trading_momentum_x Oct. 18 at 4:19 AM

$WHWK looking good to me and this one is getting some nice momentum right now. Key resistance for this one will be around that 3.8 level. If it can break that, this one can go a lot higher.

1 · Reply

_www_larval_com_ Oct. 17 at 3:22 PM

$WHWK just slipped -4% lower to -13% (~874Kv) a few minutes ago, 10/17 options, follow for more volatility.

0 · Reply

Market Cap	98.50M
Revenue (ttm)	25.98M
Net Income (ttm)	-63.69M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-245.15%
Debt to Equity Ratio	0.00

Volume	180,100
Avg Vol	2,166,366
Day's Range	N/A - N/A
Shares Out	47.13M
Stochastic %K	45%
Beta	0.58
Analysts	Hold
Price Target	$2.00